SURG vs SIFY
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 16, 2026
SURG
50.1
AI Score
VS
SURG Wins
SIFY
38.5
AI Score
Investment Advisor Scores
SIFY
39score
Recommendation
SELL
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | SURG | SIFY | Winner |
|---|
Relative Price Performance (Last 90 Days)
SURG 1M: -11.7%
· 3M: -59.4%
SIFY 1M: -11.9%
· 3M: -16.1%
Current Technical Phase
SURG
MarkdownSell / avoid
Price below a falling SMA50 (slope -22.7%), weak momentum, RSI 35
SIFY
MarkdownSell / avoid
Price below a falling SMA50 (slope -4.3%), weak momentum, RSI 23
Fundamentals Snapshot
| Metric | SURG | SIFY |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 12.7 | 587.5 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.4% | 0.2% |
| Gross Margin | -0.2% | 0.4% |
| Operating Margin | 0.2% | 0.1% |
| EPS | -1.50 | -0.13 |
| Dividend Yield | — | — |
Frequently Asked Questions
Based on our detailed analysis, SURG is currently the stronger investment candidate based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.